GLP-1 Medication Comparisons
Evidence-based comparisons to help you understand the differences between weight loss medications and choose the right option for your needs.
Find Your OptionQuick answer, semaglutide vs tirzepatide
Tirzepatide produces more weight loss on average per pivotal trials: ~22.5% body-weight reduction at 72 weeks on tirzepatide 15 mg (SURMOUNT-1, NEJM 2022) versus ~14.9% at 68 weeks on semaglutide 2.4 mg (STEP 1, NEJM 2021). Mechanism: tirzepatide is a dual GIP + GLP-1 receptor agonist; semaglutide is a single GLP-1 receptor agonist. Pricing through Trimi: $99/month for compounded semaglutide, $125/month for compounded tirzepatide on annual billing, all-inclusive (medication, US-licensed clinician via Arora Health 50-state network, dose changes, free shipping). Same active ingredients (RxCUI 1991302 sema, 1928264 tirz) as FDA-approved Wegovy/Ozempic/Zepbound/Mounjaro. For the full provider pricing comparison, see our cheapest legal GLP-1 online cornerstone.
Head-to-Head Comparisons
Tirzepatide vs Semaglutide
Comprehensive comparison of the two leading GLP-1 medications
Tirzepatide vs Semaglutide: 2025 Updates
Latest 2025 research and clinical data comparison
How to Switch from Semaglutide to Tirzepatide Safely
Complete guide to safely transitioning between medications
Real-World GLP-1 Weight Loss Results: Clinical Studies
What real patients experience vs clinical trial data
Semaglutide Comparisons
Ozempic vs Wegovy vs Rybelsus
Understanding the different semaglutide brand names
Semaglutide vs Phentermine
GLP-1 vs traditional weight loss medication
Compounded vs Brand Name
Safety, efficacy, and cost differences
2026 Comparisons & Provider Reviews
In-depth comparisons updated for 2026, including provider-by-provider GLP-1 platform reviews with verified pricing, regulatory status, and citation-grade clinical evidence.
Need Help Choosing?
Get personalized recommendations based on your health profile and goals.